New PET tracer could spot dangerous blood clots directly
NCT ID NCT06057844
First seen Jun 09, 2026 · Last updated Jun 13, 2026 · Updated 1 time
Summary
This study aims to develop a new radioactive tracer for PET scans that can directly detect active blood clots in veins. Current methods look for blockages indirectly, but this tracer targets a protein found in fresh clots. Researchers will test the tracer on blood samples from 10 healthy adult volunteers to see how well it binds to clots. If successful, this could lead to faster and more accurate diagnosis of deep vein thrombosis and pulmonary embolism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Etablissement francais du sang
RECRUITINGBrest, 29200, France
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.